4//SEC Filing
MCNEILL JOHN A JR 4
Accession 0001033408-09-000001
CIK 0001003124other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 2:17 PM ET
Size
27.4 KB
Accession
0001033408-09-000001
Insider Transaction Report
Form 4
MCNEILL JOHN A JR
Director
Transactions
- Other
Common Stock
2008-11-17−100,000→ 2,723,571 total(indirect: By Trust) - Other
Common Stock
2008-10-27−100,000→ 2,823,571 total(indirect: By Trust) - Award
Common Stock
2009-01-02+2,242→ 43,713 total
Holdings
- 8,000
Stock Options (to buy)
Exercise: $6.25From: 1999-05-12Exp: 2009-05-11→ Common Stock (8,000 underlying) - 10,489(indirect: By Children)
Common Stock
- 10,156(indirect: By Trust)
Common Stock
- 1,195(indirect: By LLC)
Common Stock
- 16,000
Stock Options (to buy)
Exercise: $4.50From: 2000-05-16Exp: 2010-05-15→ Common Stock (16,000 underlying) - 6,265
Stock Options (to buy)
Exercise: $42.77From: 2008-05-21Exp: 2018-05-20→ Common Stock (6,265 underlying) - 3,973
Stock Options (to buy)
Exercise: $35.38From: 2006-05-17Exp: 2016-05-16→ Common Stock (3,973 underlying) - 6,126
Stock Options (to buy)
Exercise: $33.82From: 2007-05-16Exp: 2017-05-15→ Common Stock (6,126 underlying) - 12,000
Stock Options (to buy)
Exercise: $12.81From: 2002-05-15Exp: 2012-05-14→ Common Stock (12,000 underlying) - 5,458
Stock Options (to buy)
Exercise: $23.79From: 2005-05-18Exp: 2015-05-17→ Common Stock (5,458 underlying)
Documents
Issuer
PHARMACEUTICAL PRODUCT DEVELOPMENT INC
CIK 0001003124
Entity typeother
Related Parties
1- filerCIK 0001033408
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 2:17 PM ET
- Size
- 27.4 KB